tbuckley/cabot-search huggingface dataset:
October Fly
Authors: George N. Braman
Journal: Annals of Internal Medicine (2010)

Ad Libitum2 February 2010October FlyGeorge N. Braman, MDGeorge N. Braman, MDFrom Bronx, NY 10471-1609.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-152-3-201002020-00010 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail An October fly flew across the room:With summer gone it was out of season—Only a poet's eye would dare assumeIts squatter's rights, lacking rhyme or reason.Why should we cast it in so bad a light,A creature after all like you and me,Perhaps its aimless and erratic flightHad meaning that another fly could see.I wondered if its meandering waysHad any purpose hidden or obscure;Or if these lingering October daysContained some secret fly-enlightened lore.I spied it last in indolent repose,Delighting in an end-of-summer doze. Author, Article, and Disclosure InformationAffiliations: From Bronx, NY 10471-1609.Current Author Address: George N. Braman, MD, 5903 Liebig Avenue, Bronx, NY 10471-1609. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 2 February 2010Volume 152, Issue 3Page: 181 ePublished: 2 February 2010 Issue Published: 2 February 2010 Copyright & PermissionsCopyright © 2010 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Divine Paradise
Authors: Steven A Sumner
Journal: Annals of Internal Medicine (2008)

On Being a Doctor2 December 2008Divine ParadiseSteven A. Sumner, BSSteven A. Sumner, BSFrom Medical College of Wisconsin, Milwaukee, WI 53226.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-149-11-200812020-00014 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Miguel went to a place called Divine Paradise. He was brought there in a truck with 25 other bodies and a police escort.Divine Paradise is the municipal cemetery in Tegucigalpa, Honduras. The gangs of the city roam freely there, robbing those who come to mourn. If you go there on official business, such as burying the dead, the police will come along to protect you.Divine Paradise is filling up. It is the site of the mass graves for the local Honduran public hospital system. It is the site where Miguel went, in a shared and unmarked hole, stacked ... Author, Article, and Disclosure InformationAffiliations: From Medical College of Wisconsin, Milwaukee, WI 53226.Corresponding Author: Steven A. Sumner, BS, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226; e-mail, [email protected]edu. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 2 December 2008Volume 149, Issue 11Page: 834KeywordsAutopsyBloodPathologistsSafetyShouldersSpinal cordTaxesThorax ePublished: 2 December 2008 Issue Published: 2 December 2008 Copyright & PermissionsCopyright © 2008 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Platelet function and simultaneous thrombelastograms from whole blood and plasma
Authors: Ion S. Jovin, Uwe Taborski, Kathrin Heidinger, Svetlana Basser, Gert Müller‐Berghaus
Journal: American Journal of Hematology (1998)

lymph node involvement with rt ureter compression that required a stent insertion.Brain CT showed a suprasellar lesion involving the diencephalic and chiasmatic regions (Fig. 1a).The patient was treated with CdA (2 hr-infusion of 0.14 mg/kg die × 7 days) and Dexamethasone (0.3 mg/kg die × 4 days).Therapy was well tolerated without significant hematologic toxicity (WHO G4 leukopenia duration, 3 days; no thrombocytopenia).Partial regression of the liver, kidney, and lymph node involvement and complete regression of the brain lesions (Fig. 1b) were documented 1 month later by CT.The patient was discharged on May 24 with complete regression of the neurological symptoms.On June 13 she died from an acute cerebral vascular accident (CVA) of ischemic origin (brain CT not shown).In this patient, a single cycle of CdA induced complete regression of the brain lesion.CVA as a complication of therapy with CdA has not been reported; a relationship between treatment and the final event is unlikely.
Airway... Instantly
Authors: R. Peter Oppenheimer
Journal: JAMA (1975)

<h3>To the Editor.—</h3> In reference to Dr. Ritter's and Dr. Weille's letters, I certainly agree that a coniotomy is a procedure that should be done when<i>all</i>other methods are unavailable. It is<i>not</i>meant to supplant the usual methods of establishing an airway, and I certainly agree that if a competent endoscopist is present, insertion of an endotracheal tube is a much preferable method to coniotomy. An orderly tracheotomy in an operating room is preferred to a coniotomy. The method is illustrated<i>only</i>to give the person in medicine and the educated layman an idea of how to establish an airway in an<i>emergency</i>(not routinely) when all other methods of establishing an airway are unavailable. Mouth-to-mouth resuscitation is, of course, useless if there is an obstruction in the airway, and unless the obstruction is removed by endoscopy or circumvented by means of a tracheotomy or coniotomy (in an
Hazard ratios
Authors: P. Sedgwick
Journal: BMJ (2011)

Researchers investigated whether BCG revaccination at 19 months of age reduced child mortality. A randomised controlled trial was performed in Guinea-Bissau, west Africa. In total 1437 children were randomised to BCG revaccination and 1434 to no revaccination (controls). All trial participants had been vaccinated at birth and on the day of enrolment had low or no reactivity to tuberculin and were not severely sick.1 Children were followed from 19 months until 5 years of age. During follow-up 77 children died. The hazard ratio of death for the revaccinated children, compared with controls, was 1.2 (95% confidence interval 0.77 to 1.89). Which of the following statements, if any, are true?
A longitudinal study of a harlequin infant presenting clinicallyas non-bullous congenital ichthyosiform erythroderma
Authors: M. HAFTEK, F. CAMBAZARD, D. DHOUAILLY, A. RÉANO, M. SIMON, A. LACHAUX, G. SERRE, A. CLAUDY, D. SCHMITT
Journal: British Journal of Dermatology (1996)
Persistent vomiting of bile in a premature infant
Authors: W. L. Smith
Journal: JAMA (1975)

<h3>History</h3> A 12-hour-old premature infant was first seen with persistent bilious vomiting. He had not yet been fed and had passed meconium ten hours after birth. On physical examination, he was found to have peculiar facies and upper abdominal distention. Figures 1 and 2 were obtained as part of the diagnostic evaluation. <h3>Diagnosis</h3> Duodenal atresia. <h3>Comment</h3> Figures 1 and 2 show two air-filled upper abdominal structures representing the very dilated stomach and duodenal bulb. The remainder of the alimentary tract was gasless. This combination of findings suggested congenital duodenal obstruction. Further inspection of Fig 1 disclosed an unusual configuration of the pelvis. The superior margins of the acetabula were flat and the ilia were flared. These findings suggested Down syndrome (trisomy 21), a condition commonly associated with duodenal atresia. Duodenal obstruction accounts for about 25% of all cases of alimentary tract obstruction in newborns. It occurs in about 1 in
Effect of Beta-Oxidized Nitrosamines on Syrian Golden Hamsters. I. 2-Hydroxypropyl-n-propylnitrosamine2
Authors: Parviz Pour, Friedrich W. Krüger, Jürgen Althoff, Antonio Cardesa, Ulrich Mohr
Journal: JNCI Journal of the National Cancer Institute (1974)

Journal Article Effect of Beta-Oxidized Nitrosamines on Syrian Golden Hamsters. I. 2-Hydroxypropyl-n-propylnitrosamine Get access Parviz Pour, Parviz Pour Search for other works by this author on: Oxford Academic PubMed Google Scholar Friedrich W. Krüger, Friedrich W. Krüger Search for other works by this author on: Oxford Academic PubMed Google Scholar Jürgen Althoff, Jürgen Althoff Search for other works by this author on: Oxford Academic PubMed Google Scholar Antonio Cardesa, Antonio Cardesa Search for other works by this author on: Oxford Academic PubMed Google Scholar Ulrich Mohr Ulrich Mohr Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 52, Issue 4, April 1974, Pages 1245–1249, https://doi.org/10.1093/jnci/52.4.1245 Published: 01 April 1974 Article history Received: 03 October 1973 Accepted: 28 December 1973 Published: 01 April 1974
THE FAUCIAL TONSILS AS POINTS OF ENTRANCE OF TUBERCULOSIS IN YOUNG CHILDREN.
Journal: JAMA (1900)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
A phase II trial of biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, interferon, and digoxin in melanoma patients
Authors: M. I. Khan, D. A. Laber, J. Chesney, B. Taft, D. M. Miller
Journal: Journal of Clinical Oncology (2008)

20021 Background: Recent studies indicate that cardiac glycosides have anti-neoplastic activities. Digoxin prevents the growth of mammary tumors in susceptible mice. Several cell lines are sensitive to cardiac glycosides including breast cancer (MCF-7), renal adenocarcinoma (TK -10), melanoma (UACC-62), leukemia (K-562), HeLa, prostate cancer and NSCLC. The mechanism of action is complex in nature and evolving. Consequently, the addition of digoxin may augment the cytotoxic effects of bio-chemotherapy against melanoma. Methods: Forty-seven patients with stage IV melanoma without CNS metastasis with a median age of 52 years (25–73), were enrolled in this open label phase II clinical trial. ECOG performance status was 0 to 1. Patients had normal cardiac, pulmonary, renal and liver function tests. Patients received digoxin 0.25 mg daily throughout all cycles. Patients were hospitalized in ICU for 5 days to receive the therapy and supportive care. Treatment schedule: dacarbazine, IV, 800 mg/m2 on day 1; cisplatin, IV, 20 mg/m2 on days 1–4; vinblastine, IV, 1.2 mg/m2 on days 1–4; IL-2, IV over 24 hours, 9 M IU/m2 on days 1–4; interferon, SC, 5 MU/m2 on days 1–5. After completing 2 cycles (28 days per cycle) patients were evaluated for response by CT and/or FDG-PET imaging studies. Patients who experienced a SD, PR, or CR then completed 2 more cycles of this therapy. There was no treatment related mortality. Common toxicities include hypotension, neutropenia, thrombocytopenia, nausea, vomiting, and renal insufficiency. Re-admission rate was less than 5%. Approximately 35% of patients required 25% dose reduction due to toxicities. Results: Ten patients achieved CR (21.3%), 16 patients had a PR (34%), and 7 patients had a SD (14.9%). The overall clinical benefit was 70%. Fourteen patients (29.8%) experienced PD and were taken off the protocol. Seventeen patients are alive. At 18 months, 3 living patients have NED. Twenty-nine patients have died due to progression of melanoma. MOS is 8 months (1–25). Conclusions: Addition of digoxin to bio-chemotherapy may have a synergistic anti-tumor effect on patients with melanoma. Accrual to this clinical trial is on-going and final overall survival and progression free survival will be presented in future. No significant financial relationships to disclose.
Racial differences in survival from breast cancer
Authors: S. A. Joslyn
Journal: JAMA (1995)

<h3>To the Editor.</h3> —I read with great interest the article by Dr Eley and colleagues<sup>1</sup>regarding racial differences in survival from breast cancer. This investigation is one of the most complete, well-designed, and well-conducted studies to determine the nature of racial differences in breast cancer survival. The data-collection methods, management of confounding factors, and statistical analyses were exceptional. I have a question for the authors regarding frequency matching of white subjects to black subjects by age. By matching (overmatching) on this important variable, possible comparisons of age as a factor in survival were eliminated. Several studies<sup>2-4</sup>have indicated significantly younger age at diagnosis in African-American women compared with white women, along with poorer survival rates, which may indicate basic biological differences between tumors in these two groups. Age may be a major explanatory variable in survival differences between races, in addition to or instead of those found in
Twilight Aqueduct
Journal: JAMA Internal Medicine (2020)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Internal Medicine HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Internal Medicine journal
The Borealis-2 clinical trial: A randomized phase 2 study of OGX-427 (Apatorsen) plus docetaxel versus docetaxel alone in relapsed/refractory metastatic urothelial cancer.
Authors: Toni K. Choueiri, Noah M. Hahn, Ajjai Shivaram Alva, Richard C. Lauer, Robert Dreicer, Joel Picus, Roberto Pili, Arjun Vasant Balar, Guru Sonpavde, Jean H. Hoffman-Censits, Elizabeth A. Guancial, Robert Alter, Meredith M. Regan, Cindy Jacobs, Patricia S. Stewart, Sumanta Kumar Pal, Jonathan E. Rosenberg
Journal: Journal of Clinical Oncology (2015)

TPS4577 Background: Heat shock protein 27 (Hsp27) is over-expressed in many cancers including bladder, lung, prostate, and breast. Increased Hsp27 has been associated with inhibition of chemotherapy-induced apoptosis, increased tumor cytoprotection, and development of treatment resistance. OGX-427 (apatorsen) is an antisense oligonucleotide designed to bind Hsp27 mRNA, inhibiting production of the Hsp27 protein. Inhibition of Hsp27 has been shown to increase apoptosis, inhibit tumor growth and metastasis, and sensitize tumor cells to chemotherapy in a variety of malignancies, including urothelial cancer. Results of preclinical and phase 1 studies suggest that addition of apatorsen to chemotherapy is well tolerated and may improve treatment efficacy. Borealis-2 is a randomized, multicenter, phase 2 study of apatorsen in combination with docetaxel (DOC) vs. DOC alone in locally advanced/metastatic bladder cancer patients who received at least one line of prior platinum-based therapy. The primary objective is to evaluate overall survival. Secondary objectives include comparisons of safety and tolerability, disease response, and serum levels of Hsp27 and other pathway-related proteins. Associations between clinical outcomes, levels of Hsp27 and other proteins, and circulating tumor cells will be evaluated. Methods: Patients (N = 200) are randomized in a 1:1 ratio following stratification (time from prior systemic chemotherapy; Bellmunt criteria). Up to 2 prior systemic therapies are allowed. Treatment-arm patients receive three loading doses of apatorsen (600 mg) followed by up to ten 21-day treatment cycles (apatorsen 600 mg on Days 1, 8, and 15 and DOC 75 mg/M2 IV on Day 1). Control-arm patients receive DOC 75 mg/M2 IV on Day 1 of each cycle. Treatment may continue until disease progression, unacceptable toxicity, completion of ten cycles, or patient withdrawal. Patients who discontinue DOC due to toxicity after ≥ 2 cycles and do not have disease progression may receive maintenance therapy with apatorsen. One interim futility analysis will be performed. The trial will not be stopped early based on efficacy. Clinical trial information: NCT01780545.
A CENTURY OF ANAESTHESIA
Authors: J. H. T.
Journal: JAMA (1960)

If more medical historians were endowed with his capabilities and displayed the same interest in the Gilbert and Sullivan approach to the subject as W. Stanley Sykes,<sup>1</sup>how delightful the dreary discourses could become. I am fully aware that Gilbert and Sullivan were not sufficiently sophisticated for some critics, but for me they composed pleasing words and verse on many subjects, including gout, as in "I Stole The Prince" from The Gondoliers. In a similar style, Sykes has described with levity the first 100 years of anaesthesia. He has included a number of asides in his history that would be appropriate in an Alexander King profile in<i>The New Yorker</i>. Sykes has wandered far in some instances, but he has not wandered alone. He takes his readers along and none dares forsake him for fear of losing an interesting incident, related or unrelated to anaesthesia. How satisfying it must
一项在最佳部位进行活检以确诊寻常天疱疮或黏膜类天疱疮的研究
Authors: B. Carey, S. Joshi, A. Abdelghani, J. Mee, M. Andiappan, J. Setterfield
Journal: British Journal of Dermatology (2020)

寻常天疱疮 (PV) 和黏膜类天疱疮 (MMP) 是罕见且可能严重的疾病,可导致口腔、鼻、咽喉、食管、生殖器和皮肤出现疼痛性水疱或糜烂。MMP 独特的主要并发症之一是可能使受累部位留下疤痕,尤其是眼睛。这两种疾病通常发生在老年人中。 为确认 PV 和 MMP 的诊断,通常在受累部位附近(病灶周围)进行活检。如果仅累及黏膜表面,口腔是最易触及的部位,但是这可能很困难,因为口腔黏膜脆弱。 该研究的目的是比较看起来正常健康的脸颊内部黏膜组织(颊黏膜)活检与病灶周围活检的结果。英国的作者分析了 251 例 MMP 和 77 例 PV 患者的活检位置和结果。 他们已经证明,正常颊黏膜组织活检与病灶周围活检在诊断口腔 PV 方面一样好。对于累及多个口腔表面的 MMP 患者,在诊断方面,正常颊黏膜活检几乎与病灶周围取样一样。对于仅累及牙龈的 MMP 患者,牙龈的病灶活检或正常颊黏膜活检并不能总是可靠地确认诊断。重要的是,对于这群患者,作者表明,从颊黏膜和牙龈黏膜之间连接处进行的活检在所有病例中均呈阳性结果。 从正常颊黏膜组织进行穿刺活检是一种诊断所有口腔 PV 患者和所有 MMP 患者的简单安全的实用方法,但仅有牙龈病变的患者除外。 本摘要涉及研究: 诊断黏膜类天疱疮和寻常天疱疮的最佳口腔活检部位
The Propaganda for Reform
Journal: JAMA (1926)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Die pathologisch-histologischen Untersuchungsmethoden
Journal: JAMA (1934)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Correction
Journal: BMJ (1956)

MEANY QSTIONS?MDICAL JOURNAL orifices of the segmental bronchi are visible.It is difficult to assess the probable value of routine chest radiographs.Certainly symptoms may appear before x-ray shadows are evident, and in many cases where the disease has come to light as the result of routine radiography careful inquiry will show that there have in fact been some suspicious symptoms.(2) If routine radiography is to be relied upon for a really early diagnosis of bronchial carcinoma, frequent ex- aminations will be necessary.It would be futile to suggest examinations at intervals of more than three months, for in three months a rapidly growing carcinoma can become inoperable.For a complete survey, right and left oblique and lateral views would be desirable.(3) The only other way of detecting early lung cancer is bronchoscopy; and this should be regarded as comple- mentary, rather than alternative, to radiography.Perhaps the prospect of three-monthly bronchoscopy might be used to discourage the desire to continue smoking.
Correction: Digitalis in general practice
Journal: BMJ (1978)

feet.A poor response to simple treatment (such as a diuretic or a beta-blocker or both) should lead us to review the position and ask ourselves, before we start a complicated regimen, whether the original state of the patient really warranted this.It seems reasonable to look on hyperlipidaemia and coronary artery disease as additional reasons for maintaining good blood TABLE iII-Contraindications and indications for specific drugs Condition Drugs contraindicated Are there any contraindications to specific drugs ?Gout, diabetes, hypokalaemia Thiazides If so, avoid these Asthma, heart failure, Beta-blockers drugs if possible Raynaud's disease, atrioven- tricular block (especially 2nd degree or complete) Depression Reserpine, methyldopa,
CS1 Promotes Multiple Myeloma Cell Adhesion, Clonogenic Growth, and Tumorigenicity Via C-Maf-Mediated Interactions with Bone Marrow Stromal Cells (BMSCs)
Authors: Yu-Tzu Tai, Ender Soydan, Mariateresa Fulciniti, Weihua Song, Xian-Feng Li, Peter Burger, Fangxin Hong, Giovanni Tonon, Kihyun Kim, Mathew J. Rumizen, Sabikun Nahar, Klaus Podar, Dharminder Chauhan, Teru Hideshima, Daniel R. Carrasco, Nikhil C Munshi, Daniel Afar, Kenneth C. Anderson
Journal: Blood (2008)